
FDA Warns About Counterfeit Versions of Diabetes Drug Ozempic
Voice of America
FILE - A pharmacist displays boxes of Ozempic, a drug used for treating type 2 diabetes and obesity made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, March 29, 2023.
The U.S. Food and Drug Administration on Thursday warned consumers not to use counterfeit versions of Novo Nordisk's diabetes drug Ozempic that have been found in the country's drug supply chain.
More Related News
